RecruitingPhase 2NCT05892614
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Studying Interstitial lung disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- aTyr Pharma, Inc.
- Principal Investigator
- Lisa CareyaTyr Pharma, Inc.
- Intervention
- efzofitimod 450 mg(drug)
- Enrollment
- 25 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (13)
- aTyr Investigative Site, Los Angeles, California, United States
- aTyr Investigative Site, San Diego, California, United States
- aTyr Investigative Site, Miami, Florida, United States
- aTyr Investigative Site, Chicago, Illinois, United States
- aTyr Investigative Site, New Orleans, Louisiana, United States
- aTyr Investigative Site, New York, New York, United States
- aTyr Investigative Site, Cleveland, Ohio, United States
- aTyr Investigative Site, Oklahoma City, Oklahoma, United States
- aTyr Investigative Site, Charleston, South Carolina, United States
- aTyr Investigative Site, Dallas, Texas, United States
- aTyr Investigative Site, Houston, Texas, United States
- aTyr Investigative Site, Salt Lake City, Utah, United States
- aTyr Investigative Site, Richmond, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05892614 on ClinicalTrials.govOther trials for Interstitial lung disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07283081Impact of Capillaroscopy in the Investigation of Diffuse Interstitial PneumoniasUniversity Hospital, Bordeaux
- RECRUITINGNANCT07254338Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension TreatmentHospices Civils de Lyon
- RECRUITINGNANCT07301697Safety and Performance Profile of Cryobiopsy in Bronchial EndoscopyUniversity Hospital, Strasbourg, France
- RECRUITINGNANCT07300696Functional MRI for Monitoring Progression and Assessing Trends in ILDUniversity Hospital Heidelberg
- RECRUITINGPHASE2NCT06053164Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung DiseaseUniversity of Alberta
- RECRUITINGNCT05819385Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)Boehringer Ingelheim
- RECRUITINGNCT06948942Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung DiseaseGazi University
- RECRUITINGNCT06235645dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasoundUniversity Hospital, Tours